COVID 19 Associated Coagulopathy
7
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
8 treatments under study, led by Troxerutin Low Molecular Weight Heparin
Research Leaders
9 sponsors active, led by University of Iowa
Related Conditions
Often studied with 15 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.4% vs benchmark
14%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (7)
Observational Study of Intranasal IVIG in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients Undergoing Medical Tourism
A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 Patients
University Hospital of Ioannina COVID-19 (Coronavirus Disease 2019) Registry
Cardiovascular Complications in Children With COVID 19
Covid-19 Associated Coagulopathy
Prevalence of Thrombophilic Gene Polymorphism (MTHFR C677T) in COVID-19patients
Coagulation Disturbances in COVID-19 Septic Patients
Research Network
Common Treatments
- Troxerutin Low Molecular Weight Heparin1
- Cac In Septic Patients1
- Placebo Low Molecular Weight Heparin1
- Covid 19 Swap1
- Intermediate Dose Thromboprophylaxis1
Active Sponsors
- University of Iowa1
- Tamara C Tamas1
- Assiut University1
- Shaoxing Central Hospital1
- Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University1
Top Investigators
StemSolutions.mx
Ain Shams University
Related Conditions
- Septic Shock1
- Covid19 Pandemic1
- Covid19associated Pneumonia1
- Covid19 Coronavirus Disease 20191
- Postacute Sequelae Of Sarscov2 Infection1